Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophsCERVIA, Davide; NUNN, Caroline; FEHLMANN, Dominique et al.British journal of pharmacology. 2003, Vol 139, Num 1, pp 109-121, issn 0007-1188, 13 p.Article

In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumorsFLORIO, Tullio; MONTELLA, Liliana; CORSARO, Alessandro et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2465-2471, issn 0250-7005, 7 p.Article

Octreotide as a therapeutic option for management of chylothoraxAL-ZUBAIRY, Sulaiman A; AL-JAZAIRI, Abdulrazaq S.The Annals of pharmacotherapy. 2003, Vol 37, Num 5, pp 679-682, issn 1060-0280, 4 p.Article

Orbital scintigraphy with the somatostatin receptor tracer ^99mTc-P829 in patients with Graves' diseaseBURGGASSER, Georg; HURTL, Ingrid; HAUFF, Wolfgang et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 10, pp 1547-1555, issn 0161-5505, 9 p.Article

Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapyBLICH, M; FRUCHTER, O; EDELSTEIN, S et al.Scandinavian journal of gastroenterology. 2003, Vol 38, Num 7, pp 801-803, issn 0036-5521, 3 p.Article

The influence of insulin on circulating ghrelinFLANAGAN, Daniel E; EVANS, Mark L; MONSOD, Teresa P et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 47, Num 2, pp E313-E316, issn 0193-1849Article

An intrapatient comparison of ^99mTc-EDDA/HYNIC-TOC with ¹¹¹In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumorsGABRIEL, Michael; DECRISTOFORO, Clemens; DONNEMILLER, Eveline et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 5, pp 708-716, issn 0161-5505, 9 p.Article

Expression of somatostatin receptors 3, 4, and 5 in mouse kidney proximal tubulesBATES, Carlton M; KEGG, Heather; PETREVSKI, Christina et al.Kidney international. 2003, Vol 63, Num 1, pp 53-63, issn 0085-2538, 11 p.Article

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic systemÖBERG, K; KVOLS, L; CAPLIN, M et al.Annals of oncology. 2004, Vol 15, Num 6, pp 966-973, issn 0923-7534, 8 p.Article

Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neckDUET, Michèle; SAUVAGET, Elisabeth; PETELLE, Boris et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 11, pp 1767-1774, issn 0161-5505, 8 p.Article

Evaluating the clinical effectiveness of ⁹⁰Y-SMT 487 in patients with neuroendocrine tumorsBUSHNELL, David; O'DORISIO, Thomas; MENDA, Yusuf et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 10, pp 1556-1560, issn 0161-5505, 5 p.Article

Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain : An immunohistochemical analysisKUMAR, U.Neuroscience. 2005, Vol 134, Num 2, pp 525-538, issn 0306-4522, 14 p.Article

Somatostatin-receptor 2 (sst₂)-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomachFYKSE, Vidar; COY, David H; WALDUM, Helge Lyder et al.British journal of pharmacology. 2005, Vol 144, Num 3, pp 416-421, issn 0007-1188, 6 p.Article

PRIMARY STRUCTURE OF OVINE HYPOTHALAMIC SOMATOSTATIN-28 AND SOMATOSTATIN-25ESCH F; BOEHLEN P; LING N et al.1980; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; USA; DA. 1980; VOL. 77; NO 11; PP. 6827-6831; BIBL. 23 REF.Article

Actualités sur la somatostatine, Symposium, Liège, 4 octobre 2001Annales d'endocrinologie. 2002, Vol 63, Num 2, issn 0003-4266, 24 p., 3Conference Proceedings

Somatostatin receptor subtypes: Targeting functional and therapeutic specificityCULLER, M.-D; TAYLOR, J.-E; MOREAU, J.-P et al.Annales d'endocrinologie. 2002, Vol 63, Num 2, pp 2S5-2S12, issn 0003-4266, 3Conference Paper

Somatostatin Actions via Somatostatin Receptors on the Ocular Surface Are Modulated by Inflammatory ProcessesMINSEL, Ivonne; MENTLEIN, Rolf; SEL, Saadettin et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 5, pp 2254-2263, issn 0013-7227, 10 p.Article

Treatment of ECL cell carcinoids with octreotide LARFYKSE, V; SANDVIK, A. K; QVIGSTAD, G et al.Scandinavian journal of gastroenterology. 2004, Vol 39, Num 7, pp 621-628, issn 0036-5521, 8 p.Article

SOMATOSTATIN 28: EFFECTS ON EXOCRINE PANCREATIC SECRETION IN CONSCIOUS DOGSSUSINI C; ESTEVE JP; VAYSSE N et al.1980; GASTROENTEROLOGY; ISSN 0016-5085; USA; DA. 1980; VOL. 79; NO 4; PP. 720-724; BIBL. 16 REF.Article

Somatostatin action on intestinal enzyme systems: effects on protein kinase and acetylcholinesterase activitiesCATALAN, R. E; MARTINEZ, A. M; ARAGONES, M. D et al.Molecular physiology. 1984, Vol 5, Num 3-4, pp 149-158, issn 0166-3178Article

Regulation of phosphoprotein phosphatase by somatostatinCATALAN, R. E; MIGUEL, B. G; GODOY, J. E et al.Biochemical medicine. 1984, Vol 31, Num 1, pp 36-41, issn 0006-2944Article

Somatostatin increases voltage-gated K⁺ currents in GH3 cells through activation of multiple somatostatin receptorsYANG, Seung-Kwon; PARKINGTON, Helena C; BLAKE, Allan D et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 11, pp 4975-4984, issn 0013-7227, 10 p.Article

Comparison of somatostatin-28 and somatostatin-14 clearance by the perfused rat liverSENO, M; SEINO, Y; TAKEMURA, Y et al.Canadian journal of physiology and pharmacology. 1985, Vol 63, Num 1, pp 62-67, issn 0008-4212Article

Truncated variants of pig somatostatin receptor subtype 5 (sst5) act as dominant-negative modulators for sst2-mediated signalingDURAN-PRADO, Mario; GAHETE, Manuel D; DELGADO-NIEBLA, Elena et al.American journal of physiology. Endocrinology and metabolism. 2012, Vol 66, Num 6, issn 0193-1849, E1325-E1334Article

In vitro antiangiogenic activity of selective somatostatin subtype-I receptor agonistsBOCCI, G; CULLER, M. D; FIORAVANTI, A et al.European journal of clinical investigation. 2007, Vol 37, Num 9, pp 700-708, issn 0014-2972, 9 p.Article